C12Y 102/01012
Glyceraldehyde-3-phosphate dehydrogenase
Official title: Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)
C12Y102/01012 (Glyceraldehyde-3-phosphate dehydrogenase) appears on 47 US grants and 96 published applications in this corpus.
Search patents in C12Y- Granted patents
- 47
- Published applications
- 96
- Assignees
- 74
- Inventors
- 229
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 2 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 2 |
| 2014 | 0 | 7 |
| 2015 | 0 | 2 |
| 2016 | 4 | 2 |
| 2017 | 2 | 5 |
| 2018 | 3 | 6 |
| 2019 | 5 | 7 |
| 2020 | 4 | 9 |
| 2021 | 4 | 3 |
| 2022 | 5 | 13 |
| 2023 | 4 | 5 |
| 2024 | 4 | 6 |
| 2025 | 2 | 3 |
| 2026 | 2 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular rheostat for cofactor balance21 Jul 2026US RE50,957 E1The Regents of the University of California
- Compositions and uses thereof27 Jan 2026US 12,533,392 B2SkinBio Therapeutics PLC
- Artificially synthesized mRNA and use of same1 Jul 2025US 12,344,864 B2Public University Corporation Nagoya City University
- Engineered microorganisms with G3P → 3PG enzyme and/or fructose-1,6-bisphosphatase including those having synthetic or enhanced methylotrophy25 Feb 2025US 12,234,463 B2Genomatica, Inc.
- Method for producing L-amino acids using microorganism containing NADP-dependent glyceraldehyde-3-phosphate dehydrogenase24 Dec 2024US 12,173,341 B2Cj Cheiljedang Corporation
- Genetically modified yeast and fermentation processes for the production of ethanol1 Oct 2026US 2026/0297503 A1Cargill, Incorporated
- Degron fusion proteins and methods of production and use thereof10 Sep 2026US 2026/0265703 A1BlueRock Therapeutics LP
- Methods for producing high-level squalene6 Aug 2026US 2026/0226485 A1Massachusetts Institute of Technology
- Compositions and uses thereof16 Jul 2026US 2026/0199428 A1Skinbiotherapeutics PLC
- Method for converting carbon source into glycolic acid2 Jul 2026US 2026/0185130 A1Nan Ya Plastics Corporation
Most cited
By later US patents
- Methods and compositions concerning siRNA's as mediators of RNA interference15US 8,058,255 B2Applied Biosystems, LLC · 2011
- Cell-free system for converting methane into fuel and chemical compounds13US 9,611,487 B2GreenLight Biosciences, Inc. · 2017
- Methylotrophic yeast producing mammalian type sugar chain10US 7,972,809 B2Kirin Beer Kabushiki Kaisha · 2011
- High potency siRNAS for reducing the expression of target genes10US 8,524,680 B2Applied Biosystems, LLC · 2013
- Gold optimized CAR T-cells8US 10,323,248 B2Chimera Bioengineering, Inc. · 2019